SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Jun-24 7:25 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 108% 4.69K to 9.74K | |
28-Jul-23 6:11 AM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 37,500 | -- | -- | 100% 0 to 37.5K | |
09-Dec-22 7:38 PM View: | Croff Enterprises Inc. (TXMD) | 06-Dec-22 | Option Exercise | 1,734 | -- | -- | 100% 0 to 1.73K | |
09-Dec-22 7:38 PM View: | Croff Enterprises Inc. (TXMD) | 06-Dec-22 | Option Sale | 440 | $4.92 | $2,165.46 | (25%) 1.73K to 1.29K | |
03-Jan-20 4:27 PM View: | Esperion Therapeutics, Inc. (ESPR) | 02-Jan-20 | Grant | 5,925 | -- | -- | 30% 20.0K to 25.93K | |
21-Mar-18 5:15 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 5,725 | $1.70 | $9,732.50 | (2%) 255.91K to 250.19K | 98% |
12-May-17 9:52 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 80,163 | -- | -- | 46% 175.75K to 255.91K | |
24-Jun-16 4:31 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 22-Jun-16 | Payment of Exercise | 10,803 | $3.34 | $36,082.00 | (6%) 186.55K to 175.75K | 99% |
18-May-16 4:31 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 16-May-16 | Market Purchase | 25,000 | $3.68 | $92,050.00 | 15% 161.55K to 186.55K | (99%) |
18-Mar-16 9:00 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 17-Mar-16 | Grant | 45,553 | -- | -- | 39% 116.0K to 161.55K | |
17-Feb-16 9:30 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 12-Feb-16 | Grant | 86,863 | -- | -- | 298% 29.14K to 116.0K | |
09-Feb-16 9:45 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Feb-16 | Acquisition (other) | 29,137 | -- | -- | 100% 0 to 29.14K | |
24-Jun-15 4:21 PM View: | Pozen, Inc. (POZN) | 22-Jun-15 | Grant | 29,137 | -- | -- | 100% 0 to 29.14K | |
30-Jan-15 9:35 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 27,911 | $36.53 | $1,019,590.00 | (100%) 27.91K to 0 | (2%) |
24-Nov-14 4:54 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 20-Nov-14 | Option Exercise | 40,750 | $20.55 | $837,250.00 | 116% 35.11K to 75.86K | |
24-Nov-14 4:54 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 20-Nov-14 | Market Option Sale | 40,750 | $33.17 | $1,351,480.00 | (54%) 75.86K to 35.11K | (4%) |
24-Nov-14 4:54 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 20-Nov-14 | Market Sale | 7,202 | $33.17 | $238,855.00 | (21%) 35.11K to 27.91K | (4%) |
20-Feb-14 5:35 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Grant | 18,875 | -- | -- | 111% 16.94K to 35.82K | |
20-Feb-14 5:35 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Payment of Exercise | 704 | $28.30 | $19,923.20 | (2%) 35.82K to 35.11K | (22%) |
11-Feb-14 9:36 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-14 | Payment of Exercise | 1,986 | $23.68 | $47,028.50 | (10%) 18.93K to 16.94K | (46%) |
04-Feb-14 4:38 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 03-Feb-14 | Payment of Exercise | 388 | $24.70 | $9,583.60 | (2%) 19.32K to 18.93K | (40%) |
11-Feb-13 5:28 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Grant | 17,140 | -- | -- | 659% 2.6K to 19.74K | |
11-Feb-13 5:28 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Payment of Exercise | 426 | $18.30 | $7,795.80 | (2%) 19.74K to 19.32K | (88%) |
05-Feb-13 4:18 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 03-Feb-13 | Payment of Exercise | 398 | $18.85 | $7,502.30 | (13%) 3.0K to 2.6K | (83%) |
07-Feb-12 5:01 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 03-Feb-12 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
30-Jul-08 6:53 PM View: | Oscient Pharmaceuticals Corp. (OSCI) | 28-Jul-08 | Grant | 10,000 | -- | -- | 38% 26.16K to 36.16K |